Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 843.20
Bid: 843.00
Ask: 843.40
Change: 0.80 (0.09%)
Spread: 0.40 (0.047%)
Open: 848.80
High: 848.80
Low: 838.40
Prev. Close: 842.40
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Debt

29 Sep 2020 17:13

RNS Number : 4937A
Informa PLC
29 September 2020
 

 Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

29 September 2020

COVID-19 Action Plan Update

Stability and Security in Financing

Informa (LSE: INF.L), the Information Services, Advanced Learning, B2B Exhibitions and Events Group today announced an update to its COVID-19 Action Plan, providing stability and security in financing through the issue of £640m equivalent Euro Bonds.

· Increased financing flexibility: Issue of £640m equivalent Euro bonds, with 5-year maturities, attractive 2.125% coupon and no financial covenants, following strong market demand for Informa credit; increases the Group's financing flexibility, with average debt maturity of 5.3 years, and combined with the repayment of US Private Placement notes lowers the Group's average cost of debt from 4.25% to 3.75%;

· Investment Grade rating: Coinciding with the Bond issue, Informa's investment grade rating re-confirmed by both S&P and Moody's, reflecting robust subscriptions revenue, long-term strength of B2B brands and pro-active steps to reduce costs and increase liquidity in the face of significant COVID-19 disruption to physical events;

· Stability and security in financing: Following bond issuance, the Group intends to renegotiate or repay US Private Placement notes, removing its point covenant and providing stability and security in financing.

Gareth Wright, Group Finance Director, Informa PLC, said:

"As outlined in our recent Half-Year Results, through our COVID-19 Action Plan we are taking a series of actions to ensure the Stability and Security of the Informa Group through 2021 and beyond."

He added: "Our Cost Management Programme, which has delivered £600m to date, combined with today's bond issue and the planned renegotiation or repayment of our US Private Placement Notes, will help secure positive monthly cash flows by January 2021 and provide long-term liquidity and financing flexibility."

 

Enquiries

 

Gareth Wright, Group Finance Director

+44 (0) 20 7017 7096

Richard Garry, Group Treasurer

+44 (0) 20 7017 7049

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 3377 3445

Tim Burt / Zoe Watt - Teneo

+44 (0) 20 7240 2486

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODFLFLRALIAFII
Date   Source Headline
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSInforma Share Buyback Programme
24th Mar 202211:08 amRNSHolding(s) in Company
24th Mar 202211:05 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInforma Share Buyback Programme
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSInforma Share Buyback Programme
21st Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSInforma Share Buyback Programme
15th Mar 20225:53 pmRNSHolding(s) in Company
15th Mar 20225:35 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNS2021 Full Year Results Statement
15th Mar 20227:00 amRNSHolding(s) in Company
8th Mar 20227:00 amRNSInforma Share Buyback Programme
7th Mar 20227:00 amRNSInforma Share Buyback Programme
4th Mar 20227:00 amRNSInforma Share Buyback Programme
3rd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSInforma Share Buyback Programme
2nd Mar 20227:00 amRNSTotal Voting Rights
1st Mar 20227:00 amRNSInforma Share Buyback Programme
28th Feb 20227:00 amRNSInforma Share Buyback Programme
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSInforma Share Buyback Programme
23rd Feb 20227:00 amRNSInforma Share Buyback Programme
22nd Feb 20227:00 amRNSInforma Share Buyback Programme
21st Feb 20225:34 pmRNSHolding(s) in Company
21st Feb 20225:29 pmRNSHolding(s) in Company
21st Feb 20227:55 amRNSInforma Share Buyback Programme
18th Feb 20227:00 amRNSInforma Share Buyback Programme
17th Feb 20227:00 amRNSInforma Share Buyback Programme
16th Feb 202211:18 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSInforma Share Buyback Programme
15th Feb 20227:00 amRNSInforma Share Buyback Programme
10th Feb 20228:10 amRNSDivestment of Pharma Intelligence for £1.9bn
4th Feb 20226:03 pmRNSBlock listing Interim Review
4th Feb 20224:03 pmRNSNotice of Results
1st Feb 20224:17 pmRNSHolding(s) in Company
20th Jan 20224:58 pmRNSHolding(s) in Company
13th Jan 20225:40 pmRNSBoard Update
13th Jan 20227:00 amRNSHolding(s) in Company
12th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20225:52 pmRNSHolding(s) in Company
12th Jan 20225:51 pmRNSHolding(s) in Company
17th Dec 20212:16 pmRNSDirector/PDMR Shareholding
14th Dec 202110:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.